WAYPOINT CAPITAL ADVISORS, LLC Prometheus Biosciences, Inc. Transaction History

WAYPOINT CAPITAL ADVISORS, LLC portfolio value:

$11.39M
portfolio value

WAYPOINT CAPITAL ADVISORS, LLC quarter portfolio value change:

+109.03%
quarter

Prometheus Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +26.47% 40.41K shares 7.08M $59.01 193.07K
Q2 2022 share Decrease -35.24% -83.09K shares -4.41M $28.23 152.66K
Q1 2022 share Increase +54.43% 83.09K shares 2.68M $37.76 235.75K
Q4 2021 share Increase 0.00% 152.66K shares 6.03M $37.87 152.66K